We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hospira, Mayne to Sell Off Five Products to Get Regulatory Approval for Buyout
Hospira, Mayne to Sell Off Five Products to Get Regulatory Approval for Buyout
January 19, 2007
The FTC is set to approve a plan proposed by Hospira to acquire Australia-based generic firm Mayne Pharma for $2 billion, as long as certain conditions are met, the agency has announced.